Friday July 18, 08:30 AM
Arthro Kinetics says seeks approval for clinical studies on CaReS in Japan
LONDON (Thomson Financial) - Arthro Kinetics Plc (Stuttgart: A0JEGB - news) . said its joint venture partner PolarisRx has successfully
completed and submitted its safety and quality confirmation application to the Japanese Ministry of Health and Welfare seeking approval to begin clinical studies for its cartilage regeneration product CaReS in Japan.
The orthopaedics company also said its joint venture partner in China, Arthro-ANDA Tinajin Biologics Technology Co. (AATBT), has received a grant of 8 million yuan from the Special Funds for Technology Innovation of Tianjin Municipal Government.
This will be used by AATBT to advance CaReS into clinical studies in China in the second half of 2008, the group added.
|
Send Article by Email
Send Article by IM
Blog This with Y! 360
Printable View
